GNH USA

Europe — EMA

Nebilet (Nebivolol)

GNH USA supplies Nebilet (Nebivolol), a beta blocker for hypertension and heart failure, approved for adult patients. Request a quote for global supply.

Request sourcing

1
Pack/s

What is Nebivolol?

Nebivolol, the active ingredient in Nebilet, is a beta blocker presented as a tablet for oral use. It treats hypertension and heart failure in adult patients, helping to lower blood pressure and improve cardiac function. GNH USA supplies Nebilet as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

What is Nebivolol used for?

Nebivolol is indicated for conditions within the cardiovascular disease spectrum, primarily affecting blood pressure regulation and cardiac performance. Hypertension: lowers systolic and diastolic blood pressure, reducing the risk of cardiovascular events. Heart failure: enhances left‑ventricular ejection fraction and decreases hospitalisation rates in patients with chronic heart failure.

What are the side effects of Nebivolol?

Nebivolol may cause a range of adverse reactions, which are grouped by frequency.

Common Side Effects: - Fatigue or tiredness - Headache - Dizziness or light‑headedness - Mild nausea

Serious or Rare Side Effects: - Severe bradycardia or heart block - Marked hypotension - Bronchospasm, especially in patients with asthma or COPD - Allergic reactions such as rash, angioedema, or anaphylaxis

What precautions apply to Nebivolol?

When prescribing Nebivolol, clinicians should consider several safety measures. - Monitor blood pressure: check regularly to avoid excessive lowering. - Assess heart rate: watch for bradycardia, especially in patients with conduction disorders. - Caution in asthma/COPD: β‑blockade may exacerbate bronchospasm. - Avoid abrupt discontinuation: sudden stop can precipitate rebound hypertension. - Store at ambient temperature: keep in the original pack, protect from moisture.

What does Nebivolol interact with?

Nebivolol can interact with other medicines, requiring careful management.

Major Interactions (Avoid): - Non‑selective beta‑blockers: additive bradycardia and AV‑block risk. - Calcium‑channel blockers (verapamil, diltiazem): increased risk of severe bradycardia and heart block. - Other antihypertensives (ACE inhibitors, ARBs, diuretics): may cause excessive hypotension.

Moderate Interactions (Monitor Closely): - Diuretics: monitor electrolytes and renal function. - Antidiabetic agents: beta‑blockade may mask hypoglycaemia symptoms, requiring glucose monitoring.

Frequently asked questions

What conditions is Nebilet used to treat?+
Nebilet, containing nebivolol, is prescribed for adult patients with hypertension and chronic heart failure. In hypertension, it helps lower elevated blood‑pressure readings, while in heart failure it improves cardiac output and reduces the likelihood of hospitalisation.
How does nebivolol work to lower blood pressure?+
Nebivolol selectively blocks β1‑adrenergic receptors in the heart, decreasing heart rate and contractile force. It also stimulates nitric‑oxide release from the endothelium, causing vasodilation. The combined effect reduces systemic vascular resistance and lowers blood pressure.
What is the usual dose of Nebilet?+
The appropriate dose of Nebilet is determined by the prescribing healthcare professional based on the individual’s clinical condition, response, and tolerability. Dosage adjustments may be required for specific patient groups, and the prescriber will provide the exact regimen.
Is Nebilet safe to use during pregnancy or breastfeeding?+
Nebivolol’s safety in pregnancy and lactation has not been definitively established. It should only be used if the potential benefit justifies any possible risk to the fetus or infant, and the decision must be made by a qualified healthcare provider.
How do I order Nebilet from GNH USA?+
To request Nebilet, submit an enquiry on the product page at gnh-usa.com, specifying the required quantity. GNH USA works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.
How does Nebilet compare with other beta‑blockers?+
Nebilet (nebivolol) is a third‑generation β1‑selective blocker that also enhances nitric‑oxide‑mediated vasodilation, offering a more favourable metabolic profile and fewer central nervous system side effects compared with older non‑selective beta‑blockers such as propranolol.
What are the recommended storage conditions for Nebilet?+
Nebilet tablets should be stored at ambient temperature, below 25 °C, in the original container to protect them from moisture and light. Keep the medication out of reach of children and do not use after the expiry date.
How is Nebilet administered?+
Nebilet is taken orally as a tablet, usually with or without food. The tablet should be swallowed whole with a glass of water. Patients should follow the dosing schedule prescribed by their healthcare professional.
What are the most serious risks associated with Nebilet?+
Serious risks include severe bradycardia, marked hypotension, bronchospasm in patients with reactive airway disease, and rare allergic reactions such as angioedema. Patients experiencing these symptoms should seek immediate medical attention.
Who should not use Nebilet?+
Nebilet is contraindicated in patients with known hypersensitivity to nebivolol, those with severe bradycardia, second‑ or third‑degree heart block without a pacemaker, and individuals with uncompensated heart failure or severe hepatic impairment.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Product details

Drug
Nebivolol
Route
Oral Use
Manufacturer
Menarini International Operations Luxembourg S.A.
Origin
EU

Related products